Dr. Keerthana Nagavenkata Bolisetty is a Arlington, Texas based female Ophthalmologist with 10 years of experience in Ophthalmology. She completed her graduation from Ohio State University College Of Medicine in 2015. She is also affiliated with hospitals like Christus Mother Frances Hospital. She accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Keerthana Nagavenkata Bolisetty is S1985 in Texas.
Dr. Keerthana Nagavenkata Bolisetty is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Keerthana Nagavenkata Bolisetty speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
| Specialization: | Ophthalmology |
| Credentials: | MD |
| Experience: | 10+ years |
| Medical School Attended: | Ohio State University College Of Medicine |
| Graduation Year: | 2015 |
| Gender: | Female |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 1007 W Randol Mill Rd Ste 110, Arlington,
Texas, 76012-6503 |
| Phone: | 817-617-7678 |
| Fax: | 817-617-7678 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 5092023234 |
| Enrollment ID: | I20190626001884 |
| NPI Number: | 1407241284 |
| NPI Enumeration Date: | 30 Mar, 2015 |
| NPI Last Update On: | 23 Oct, 2022 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Keerthana Nagavenkata Bolisetty are as mentioned below.
| License Number | Specialization | State | Status | |
| S1985 | | Texas | Primary | |
| S1985 | Ophthalmology | Texas | Secondary | |
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| Christus Mother Frances Hospital (450102) | Tyler, TX | Acute Care Hospital |
Group Practice:
Group practices are run by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Keerthana Nagavenkata Bolisetty has association with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Christus Trinity Clinic (3072426741) | 954 |
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Keerthana Nagavenkata Bolisetty such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 400383205 | Medicaid | Texas | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 3824 N Tarrant Pkwy Ste 310,
Fort Worth, Texas |
| Zip: | 76244-5431 |
| Phone Number: | 817-617-7678 |
| Fax Number: | 817-617-7681 |
Patients can reach Dr. Keerthana Nagavenkata Bolisetty at
1007 W Randol Mill Rd Ste 110, Arlington, Texas or can
call to book an appointment on 817-617-7678.
Comments/ Reviews:
Patients can read all the reviews posted for Dr. Keerthana Nagavenkata Bolisetty below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Dr. Keerthana Nagavenkata Bolisetty. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.